Eyeworld Supplements

ASCRS Clinical Survey 2022

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/1483249

Contents of this Issue

Navigation

Page 4 of 7

2022 ASCRS CLINICAL SURVEY | 5 n=944 pq Statistically significant difference between segments n=944 What is your target "sweet spot" for residual refractive astigmatism during the first few weeks following cataract surgery (in diopters)? At what level of total corneal astigmatism (in diopters) do you consider implanting a toric IOL? % who have a "sweet spot" by segment 2022 Practice location U.S. 78% International 78% Years in practice Early stage (0–5years) 81% Mid stage (6–10 years) 81% Last stage (11+ years) 77% Perform majority of surgeries in Hospital outpatient department (HOPD) 82% Office 77% Gender Male 79% Female 75% % who implant toric IOls by segment 2022 Practice location U.S. 94% p International 89% Years in practice Early stage (0–5years) 92% Mid stage (6–10 years) 96% Last stage (11+ years) 94% Perform majority of surgeries in Hospital outpatient department (HOPD) 92% Office 92% Gender Male 94% p Female 86% 0.5 D or greater with-the-rule 0.3 D with-the-rule 0 D 0.3 D against-the-rule 0.5 D or greater against-the-rule I do not have a "sweet spot" 16% 36% 18% 5% 3% 22% of respondents have a target "sweet spot" for residual refractive astigmatism 78% 0.75 D 1.00 D 1.25 D 1.50 D 1.75 D I do not implant toric IOLs 25% 34% 17% 12% 4% 8% consider implanting a toric IOL 92%

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - ASCRS Clinical Survey 2022